THE ENDOCANNABINOID SYSTEM AND CARDIOMETABOLIC RISK

Slides:



Advertisements
Similar presentations
Immune Activation/Inflammation and HIV Disease Prof. Georg Behrens Department for Clinical Immunology and Rheumatology Hannover Medical School Germany.
Advertisements

Weight and Health Susan Fullmer, PhD, RD, CD Associate Teaching Professor Nutrition, Dietetics, and Food Science Brigham Young University.
Sex Differences in Overweight & Obesity.
Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.
Regulation of food intake. Food intake Regulation –Endocrine Adipose tissue Pancreas Liver Muscle –CNS.
Rimonabant: New therapeutic option for managing cardiometabolic risk.
Adiposity in CVD. Role of adipose tissue in atherogenesis Adapted from de Luca C, Olefsky JM. Nat Med. 2006;12:41-2. Lau DCW et al. Am J Physiol Heart.
Source: International Chair on Cardiometabolic Risk Fatty Acid Metabolism in Humans Michael Jensen, MD Division of Endocrinology.
Source: International Chair on Cardiometabolic Risk Role of the Dysregulated Endocannabinoid System in Determining Cardiometabolic.
Source: International Chair on Cardiometabolic Risk Abdominal Obesity, Intra-abdominal Adiposity and Related Cardiometabolic.
M ETABOLIC S YNDROME By Dr. Sumbul Fatma Clinical Chemistry Unit Department of Pathology.
RISK FACTORS FOR ATHEROSCLEROSIS IN OBESE CHILDREN  Dyslipidemia High triglycerides, VLDL Low HDL High small, dense LDL  Glucose intolerance, diabetes.
Goals: 1) Understand the mechanism for ↑LDL in Type II diabetes 2) Having previously established the link between endothelial cell damage (loss of inhibitory.
Endocrine Block | 1 Lecture | Dr. Usman Ghani
Factors Released from Adipose Tissue and their Physiological Relevance
Leveraging Weight Loss in the Treatment of Type 2 Diabetes Part 1 of 4.
Obesity Dr. Sumbul Fatma. Obesity A disorder of body weight regulatory systems Causes accumulation of excess body fat >20% of normal body weight Obesity.
The Endocannabinoid System Role in energy homeostasis and peripheral lipid and glucose metabolism.
Resistance to Leptin Action is the Major Determinant of Hepatic Triglycerides Accumulation in vivo. By Sigal Fishman, MD.
cardio protection: Focus on
Diabetes Mellitus 101 for Medical Professionals An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes: Stanley Schwartz.
The Obesity/Diabetes Epidemic: Adiposopathy & Obesity- The New Disease! Dx & (Rx) of Insulin Resistance & early DM Part 3 Stan Schwartz MD, FACP, FACE.
Plasminogen-Activating Inhibitor-1 (PAI-1) High PAI-1 associated with: Obesity (especially visceral), possible fatty liver. 2,3,4 Inflammation and oxidative.
Cardiometabolic Syndrome Nabil Sulaiman HOD Family and Community Medicine, Sharjah University and University of Melbourne & Dr Dhafir A. Mahmood Consultant.
Metabolic syndrome from a gender and cardiovascular perspective Eva Swahn.
Contemporary Management of Cardiometabolic Risk. A continuing epidemic: 2 of 3 US adults are overweight or obese National Health and Nutrition Examination.
IR and Hyperinsulinemia Insulin Resistance: A Survival Mechanism, Gone Awry Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
Obesity Dr. Sumbul Fatma. Obesity A disorder of body weight regulatory systems Causes accumulation of excess body fat >20% of normal body weight Obesity.
The Endocannabinoid System as a Pharmacologic Target in Treating Obesity Lauren Kerrick Braden Advisor: Dr. Hadley Spring 2007.
Genetic Predisposition Environmental Factors Obesity TYPE 2 DIABETES
Diabetes Mellitus Type 2
Insulin Resistance Progression to Diabetes Part 3.
METABOLISM of ADIPOSE TISSUE 2. LF UK Prof. Rudolf Poledne, PhD.
Source: International Chair on Cardiometabolic Risk Illustrations relevant to Managing CMR section.
SARCOPENIC-OBESITY AND CARDIOVASCULAR DISEASE RISK IN THE ELDERLY The Journal of Nutrition, Health & Aging Pf. 진상욱 /R2. 최하나.
Metabolic Syndrome Endocrine Block 1 Lecture Dr. Usman Ghani.
Dr. Pravin R. Bharatia M. D. KEM Hospital, Pune..
Biochemical Aspects of OBESITY
INTERVENTION IS PREVENTION: For A Healthier Community Bronx County Medical Society 10 th Annual National Doctors Recognition Day March 20, 2013 Julie J.
Novel insights into regulation of plasma triglyceride levels
Endocrine Block 1 Lecture Dr. Usman Ghani
Endocrine Block Dr. Usman Ghani
OBESITY.
OBESITY.
Chapter 7 Metabolic syndrome
Independent variables (baseline) Loge (HOMA-IR) b P
Endocrine Block | Dr. Usman Ghani
Effect of mangiferin, valsartan, rosiglitazone and their combination on a dietary model of insulin resistance syndrome Saleh Samira1, El-Maraghy Nabila2,
By Dr. Sumbul Fatma Clinical Chemistry Unit Department of Pathology
Obesity Dr. Sumbul Fatma.
THE MANY FUNCTIONS OF INSULIN IN LIPID METABOLISM
Endocrine Block 1 Lecture Dr. Usman Ghani
ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH CRITERIA FOR THE CLINICAL DIAGNOSIS OF THE METABOLIC SYNDROME AS PROPOSED BY THE NCEP-ATP III Metabolic.
Intermyocellular fat depot
Biochemical Aspects of OBESITY
Ectopic fat and cardiometabolic and vascular risk
Figure 2 Pathophysiology of hyperglycaemia in T2DM
Associations between branched chain amino acid intake and biomarkers of adiposity and cardiometabolic health independent of genetic factors: A twin study 
In and Out: Adipose Tissue Lipid Turnover in Obesity and Dyslipidemia
White adipose tissue (HFD)
Adipose tissue and reproduction in women
Insulin action after a meal.
The following slides highlight an educational review of presentations at a Satellite Symposium and the Clinical Trial Update Session at the World Congress.
“De-liver-ance” From CB1: A Way to Counteract Insulin Resistance?
A whole body model for both glucose and fatty acid metabolism
In and Out: Adipose Tissue Lipid Turnover in Obesity and Dyslipidemia
Section overview: Cardiometabolic risk reduction
CHD RISK Glycemia 75g OGTT Time Metabolic Syndrome
Neurobiology of Appetite
Presentation transcript:

THE ENDOCANNABINOID SYSTEM AND CARDIOMETABOLIC RISK Excess food intake - obesity Overactivity of the EC system Brain CB1 Gastrointestinal tract ? Food intake CB1 Genetic susceptibility? Abdominal adiposity FFA Liver Adipocytes Skeletal muscle? Adiponectin FFA CB1 TNF-α CB1 CB1 IL-6 CRP Lipogenesis LPL Lipogenesis Impaired insulin action Liver fat VLDL Glucose production Insulinemia Insulin degradation Apo AI synthesis Glucose intolerance Increased waist (abdominal obesity) Insulin resistance High triglyceride-low HDL choIesteroI dyslipidemia Pro-inflammatory profile Risk of CVD and type 2 diabetes Adapted from Després JP et al. Int J Obes 2006; 30: S44-52